Medical/Pharmaceuticals
Functional Medicine Malaysia: Emagene Life Academy Officially Launches with Successful "Good Gut Gathering" Workshop
KUALA LUMPUR, Malaysia, Jan. 26, 2026 /PRNewswire/ -- Emagene Life <>, a leading functional medicine and longevity practice in Malaysia, has officially launched the Emagene Life Academy, marking a major milestone in the advancement of functional medicine education in the region. The Academy's lau...
2026-01-27 00:37
6876
BIOSeedin Winter Innovation Partnering Summit：J.P.Morgan Spotlight
SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- To enable Chinese innovative pharmaceutical companies to more efficiently connect with international resources, bioSeedin, a platform facilitating cooperation in innovative drug assets, hosted the BIOSeedin Winter Innovation Partnering Summit inSan Fra...
2026-01-26 22:00
7895
Jin Medical International Ltd. To Host Management Fireside Chat
CHANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment inChina, announced today that its Chief Executive Officer, tog...
2026-01-26 21:57
20706
Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026
SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- Divamics (DIVAMICS), an AI-driven biotechnology company specializing in high-precision molecular discovery, highlighted the significant advancement of its internal pipeline during the Biotech Showcase™ at JPM Week 2026. The company provided updated mil...
2026-01-26 20:00
3640
Gu Sheng Tang Donates S$1.06 Million to NTU Singapore to Advance Traditional Chinese Medicine Research and Education in Singapore
SINGAPORE, Jan. 26, 2026 /PRNewswire/ -- Leading Traditional Chinese Medicine (TCM) healthcare group Gu Sheng Tang TCM and Nanyang Technological University, Singapore (NTU Singapore) officially launched theGu Sheng Tang Traditional Chinese Medicine Education and Research Programme today. As part ...
2026-01-26 18:00
5911
WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein Pipeline
SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and auto...
2026-01-26 17:35
16927
HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
SHANGHAI, TAIPEI and SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics (2269.HK), a leading global Contract Research, Developm...
2026-01-26 15:00
12903
Get Exclusive Limited-Edition Gifts During Your Lunar New Year Trip: Wakamoto Launches "Thank You from Wakamoto" Campaign
TOKYO, Jan. 26, 2026 /PRNewswire/ -- Wakamoto Pharmaceutical Co., Ltd. (Tokyo,
Arata Igarashi), a company dedicated to supporting healthy and active
lifestyles, will launch a nationwide campaign in which customers who purchase
"Strong Wakamoto" will receive an original hand towel.
2026-01-26 13:00
5919
Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
-Topline data from the Phase II study for the treatment of diabetes are expected in the third quarter of 2026. -ASC30 demonstrated placebo-adjusted weight loss of up to 7.7% in a recently completed 13-week U.S. Phase II study in participants with obesity or o verweight, withbetter gastrointestina...
2026-01-26 08:10
10986
Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard
TIANJIN, China, Jan. 26, 2026 /PRNewswire/ -- In a landmark move for the cell therapy industry, a Device Master File (DMF) describing the first dedicated quality control standard for Mesenchymal Stromal Cells (MSCs) was accepted by the U.S. Food and Drug Administration (FDA). The agency's Master ...
2026-01-26 08:00
7240
Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor
* Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study inthe United States. The Phase I clinical trial aims to evaluate safety, tolerability, and pharmacokinetics profiles. * ISM8969 is a novel oral therapeutic candi...
2026-01-23 21:30
15451
Ozelle Brings AI-Powered, Scenario-Ready Diagnostics to WHX Labs Dubai 2026
DUBAI, UAE, Jan. 23, 2026 /PRNewswire/ -- Ozelle, a global innovator in intelligent diagnostics, will showcase its next-generation solution atWHX Labs Dubai 2026 (Feb 10–13, Booth S1.D58). Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," Ozelle will highlight how dia...
2026-01-23 18:00
8615
Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
AUCKLAND, New Zealand, Jan. 21, 2026 /PRNewswire/ -- Aroa Biosurgery Limited is pleased to announce that the latest publication from its ongoing prospective study, theMyriad Augmented Soft Tissue Reconstruction Registry (MASTRR), has been published in theJournal of Trauma and Injury. MASTRR is t...
2026-01-23 03:13
6492
Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines
* New "AI GYM for Science" dramatically boosts the biological and chemical intelligence of any causal or frontier LLM * Up to 10x performance gains on key drug discovery benchmarks compared to LLMs that miss the mark on ~75–95% of tasks * Advances Insilico's vision of Pharmaceutical Superint...
2026-01-22 22:37
10749
Mindray Unveils Three-Pillar Growth Strategy at 2026 J.P. Morgan Healthcare Conference, Paving the Way for Next Decade of Global Healthcare Innovation
SHENZHEN, China, Jan. 22, 2026 /PRNewswire/ -- May Li, Board Secretary of Mindray Medical (300760.SZ), delivered a keynote speech at the 44th J.P. Morgan Healthcare Conference (JPM Conference) on January 15, 2026, outlining the company's strategic vision for the next decade centered on three core...
2026-01-22 22:11
18144
Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.
SHANGHAI, Jan. 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed ina clinical trial in the U.S. of its independently developed novel CDH17-targeting antibody-drug co...
2026-01-22 22:00
8610
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
* CEPI to provide up to USD 30 million to support development of MSD's Zaire ebolavirus vaccine * Collaboration addresses manufacturing complexity and cold-chain challenges to improve yield and thermostability * Partnership aims to expand affordable and sustainable vaccine access in low- an...
2026-01-22 21:00
8539
PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader
BURLINGTON, Mass., Jan. 22, 2026 /PRNewswire/ -- PAQ Therapeutics, a clinical-stage oncology company developing novel targeted protein degradation therapies for KRAS-driven cancers, today announced the closing of a Series B extension, bringing the company's total Series B financing to$77 million,...
2026-01-22 20:00
5753
pixelRo to Showcase AI-Powered Digital Healthcare and Air Sterilization Solutions at CES 2026 and WHX Dubai
SEOUL, South Korea, Jan. 22. 2026 /PRNewswire/ -- pixelRo, a Samsung Electronics spin-off digital healthcare company, is accelerating its global expansion by participating in CES 2026 and WHX Dubai 2026 (formerly Arab Health). pixelRo develops and operates AI-based integrated self-diagnostic kio...
2026-01-22 16:59
5217
BTL Announces Successful Enforcement of Patent Rights Relating to EMFACE® Against WonderFace Device
PRAGUE, Jan. 22, 2026 /PRNewswire/ -- BTL Group, a global leader in medical technologies, today announced the successful resolution of multiple patent infringement proceedings against Lexter Microelectronic Engineering Systems S.L. ("Lexter"), the manufacturer of the WonderFace device. The settl...
2026-01-22 16:00
5699
Week's Top Stories
Most Reposted
Visa and Marina Bay Precinct Partners - Marina Bay Sands, UOB and Singapore Tourism Board - Present 'A Moment to Savour', Bringing International Restaurant Collaborations to Singapore
[Picked up by 309 media titles]
2026-10-27 13:40
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00
Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 294 media titles]
2026-10-28 12:12
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 281 media titles]
2026-10-23 21:52
OneQode Signs 14 MW AI Capacity Agreement with AdaniConneX, with a Path to 114 MW
[Picked up by 276 media titles]
2026-10-28 09:00
Most Read
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
41381
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
41126
SwitchBot Launches AI Art Frame 2 with Full-Color E Ink and Personalized Art
2026-10-27 21:00
40395
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
32453